MPM Capital leads Series B round for iTeos Therapeutics
iTeos Therapeutics, a Belgian biopharmaceutical company, has raised 64 million euros ($74 million) in Series B funding. MPM Capital led the round which included HBM Partners, 6 Dimensions Capital, Curative Ventures and VIVES Louvain Technology Fund.
20 June 2018•1 min read
